Adam Torbicki

146.7k total citations · 10 hit papers
263 papers, 15.3k citations indexed

About

Adam Torbicki is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Adam Torbicki has authored 263 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Pulmonary and Respiratory Medicine, 143 papers in Cardiology and Cardiovascular Medicine and 61 papers in Internal Medicine. Recurrent topics in Adam Torbicki's work include Pulmonary Hypertension Research and Treatments (157 papers), Venous Thromboembolism Diagnosis and Management (61 papers) and Cardiovascular Function and Risk Factors (39 papers). Adam Torbicki is often cited by papers focused on Pulmonary Hypertension Research and Treatments (157 papers), Venous Thromboembolism Diagnosis and Management (61 papers) and Cardiovascular Function and Risk Factors (39 papers). Adam Torbicki collaborates with scholars based in Poland, Italy and United States. Adam Torbicki's co-authors include Marius M. Hoeper, Marcin Kurzyna, Gérald Simonneau, Nazzareno Galiè, Stavros Konstantinides, Horst Olschewski, Olivier Sitbon, Michael D. McGoon, Piotr Pruszczyk and Robert Naeije and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Adam Torbicki

239 papers receiving 14.8k citations

Hit Papers

2016 ESC Position Paper on cancer trea... 2004 2026 2011 2018 2016 2013 2009 2009 2004 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
    2016 1.8k citations José Luis Zamorano, Patrizio Lancellotti et al. European Heart Journal profile →
  2. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
    2013 948 citations Tomás Pulido, Richard N. Channick et al. profile →
  3. Guidelines for the diagnosis and treatment of pulmonary hypertension
    2009 893 citations Marius M. Hoeper, Marc Humbert et al. European Respiratory Journal profile →
  4. Diagnosis and Assessment of Pulmonary Arterial Hypertension
    2009 832 citations Marius M. Hoeper, Adam Torbicki et al. profile →
  5. Diagnosis and differential assessment of pulmonary arterial hypertension
    2004 731 citations Adam Torbicki, Olivier Sitbon et al. profile →
  6. Right Heart Adaptation to Pulmonary Arterial Hypertension
    2013 706 citations Adam Torbicki et al. profile →
  7. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
    2020 619 citations Adam Torbicki et al. profile →
  8. Diagnosis of pulmonary hypertension
    2018 297 citations Adam Torbicki et al. European Respiratory Journal profile →
  9. The pathophysiology of chronic thromboembolic pulmonary hypertension
    2017 290 citations Gérald Simonneau, Adam Torbicki et al. profile →
  10. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function
    2017 252 citations Victor Aboyans, Stavros Konstantinides et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Torbicki Poland 50 10.6k 9.7k 3.0k 1.7k 1.7k 263 15.3k
Iréne Lang Austria 74 12.3k 1.2× 11.7k 1.2× 3.3k 1.1× 2.4k 1.4× 3.3k 2.0× 527 20.4k
Marion Delcroix Belgium 48 6.6k 0.6× 9.6k 1.0× 1.6k 0.5× 1.8k 1.0× 1.3k 0.8× 266 11.7k
C. Gregory Elliott United States 47 4.4k 0.4× 6.5k 0.7× 2.2k 0.7× 1.0k 0.6× 1.6k 0.9× 132 9.7k
Florence Parent France 43 5.2k 0.5× 6.5k 0.7× 2.8k 0.9× 1.8k 1.1× 1.5k 0.9× 122 9.6k
Richard N. Channick United States 51 9.1k 0.9× 13.0k 1.3× 1.5k 0.5× 2.9k 1.7× 1.5k 0.9× 222 14.7k
Rogério Souza Brazil 39 6.8k 0.6× 11.8k 1.2× 589 0.2× 2.3k 1.3× 1.6k 1.0× 180 13.5k
Dave P. Miller United States 58 6.4k 0.6× 8.1k 0.8× 359 0.1× 1.3k 0.8× 2.1k 1.2× 119 12.8k
Xavier Jaïs France 62 6.8k 0.6× 11.4k 1.2× 875 0.3× 2.6k 1.5× 1.7k 1.0× 261 12.7k
Diana Bonderman Austria 41 5.3k 0.5× 4.1k 0.4× 982 0.3× 803 0.5× 1.1k 0.7× 155 8.6k
Vallerie V. McLaughlin United States 64 13.5k 1.3× 19.4k 2.0× 658 0.2× 3.7k 2.1× 2.1k 1.3× 273 21.5k

Countries citing papers authored by Adam Torbicki

Since Specialization
Citations

This map shows the geographic impact of Adam Torbicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Torbicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Torbicki more than expected).

Fields of papers citing papers by Adam Torbicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Torbicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Torbicki. The network helps show where Adam Torbicki may publish in the future.

Co-authorship network of co-authors of Adam Torbicki

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Torbicki. A scholar is included among the top collaborators of Adam Torbicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Torbicki. Adam Torbicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Florczyk, Michał, Marta Banaszkiewicz, Aleksandra Gąsecka, et al.. (2025). Sex-Specific Differences in Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty. Journal of Clinical Medicine. 14(3). 899–899.
2.
Torbicki, Adam, et al.. (2024). Myo‐inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline‐induced pulmonary hypertension in the rat. British Journal of Pharmacology. 181(20). 4050–4066. 1 indexed citations
3.
Mackiewicz, Urszula, Cezary Szczylik, Marcin Kurzyna, et al.. (2023). Role of Oxygen Starvation in Right Ventricular Decompensation and Failure in Pulmonary Arterial Hypertension. JACC Heart Failure. 12(2). 235–247. 6 indexed citations
4.
Wieteska, Maria, Robert Ryczek, Sebastian Szmit, et al.. (2023). Outcomes of COVID-19 in patients vaccinated and unvaccinated against SARS-CoV-2 and suffering from pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Polskie Archiwum Medycyny Wewnętrznej. 133(5). 3 indexed citations
5.
Wróbel, Krzysztof, Szymon Darocha, Marcin Kurzyna, et al.. (2023). Acute pulmonary embolism with coexisting right heart thrombi in transit—surgical treatment of 20 consecutive patients. European Journal of Cardio-Thoracic Surgery. 63(4). 6 indexed citations
6.
Darocha, Szymon, Michał Florczyk, Marta Banaszkiewicz, et al.. (2023). The Utility of a Resting Electrocardiogram (ECG-PH Index) in Evaluating the Efficacy of Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension. Journal of Clinical Medicine. 12(24). 7621–7621.
7.
Darocha, Szymon, Aleksander Araszkiewicz, Marcin Kurzyna, et al.. (2021). Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary Hypertension. Journal of Clinical Medicine. 10(5). 1038–1038. 24 indexed citations
8.
Mańczak, Małgorzata, Szymon Darocha, Marta Banaszkiewicz, et al.. (2021). Assessment of Clinical Usefulness of Resting Electrocardiogram (PH-ECG Score) in Monitoring the Efficacy of Balloon Pulmonary Angioplasty (BPA) in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Journal of Clinical Medicine. 10(19). 4548–4548. 3 indexed citations
9.
Banaszkiewicz, Marta, Arkadiusz Pietrasik, Michał Florczyk, et al.. (2021). Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty. Diagnostics. 11(1). 133–133. 8 indexed citations
10.
Gąsecka, Aleksandra, Marta Banaszkiewicz, Rienk Nieuwland, et al.. (2021). Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension. Journal of Clinical Medicine. 10(5). 1024–1024. 25 indexed citations
11.
Darocha, Szymon, Marta Banaszkiewicz, Maria Wieteska, et al.. (2020). Assessment of electrocardiographic markers of acute and long‐term hemodynamic improvement in patients with pulmonary hypertension. Annals of Noninvasive Electrocardiology. 25(5). e12758–e12758. 13 indexed citations
12.
Darocha, Szymon, Radosław Pietura, Marta Banaszkiewicz, et al.. (2020). Balloon Pulmonary Angioplasty with Stent Implantation as a Treatment of Proximal Chronic Thromboembolic Pulmonary Hypertension. Diagnostics. 10(6). 363–363. 8 indexed citations
13.
Kurzyna, Marcin, Katarzyna Małaczyńska-Rajpold, Agnieszka Pawlak, et al.. (2017). An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil. BMC Pulmonary Medicine. 17(1). 162–162. 18 indexed citations
14.
Zamorano, José Luis, Patrizio Lancellotti, Daniel Muñoz, et al.. (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. European Heart Journal. 37(36). 2768–2801. 1750 indexed citations breakdown →
15.
Torbicki, Adam, Arnaud Perrier, Stavros Konstantinides, et al.. (2016). GUIDELINES ON THE DIAGNOSIS AND MANAGEMENT OF ACUTE PULMONARY EMBOLISM. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Jing, Zhi‐Cheng, Keyur Parikh, Tomás Pulido, et al.. (2013). Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension. Circulation. 127(5). 624–633. 242 indexed citations
17.
Sitbon, Olivier, Richard N. Channick, Marion Delcroix, et al.. (2013). Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH). European Respiratory Journal. 42(Suppl 57). P4060–P4060. 5 indexed citations
18.
Mayer, Eckhard, Andrea Maria D’Armini, Hossein Ardeschir Ghofrani, et al.. (2013). Efficacy of riociguat in patients with inoperable CTEPH vs persistent/recurrent PH after pulmonary endarterectomy (PEA): Results from the phase III CHEST-1 study. European Respiratory Journal. 42(Suppl 57). 1781–1781. 2 indexed citations
19.
Hoeper, Marius M., et al.. (2009). Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal. 34(6). 1219–1263. 893 indexed citations breakdown →
20.
Achenbach, Stephan, et al.. (2009). European Perspectives. Circulation. 119(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iréne Lang Breakdown of academic impact, for papers by Marion Delcroix Breakdown of academic impact, for papers by C. Gregory Elliott Breakdown of academic impact, for papers by Florence Parent Breakdown of academic impact, for papers by Richard N. Channick Breakdown of academic impact, for papers by Rogério Souza Breakdown of academic impact, for papers by Dave P. Miller Breakdown of academic impact, for papers by Xavier Jaïs Breakdown of academic impact, for papers by Diana Bonderman Breakdown of academic impact, for papers by Vallerie V. McLaughlin
Rankless by CCL
2026